Papadimitrakopoulou V, et al. IMPOWER132: PFS and safety results with 1L atezolimumab + carboplatin/cisplatin + pemetrexed in stage IV non-squamous NSCLC. IASLC 2018; abstract OA05.07.
Radioembolisatie levertumoren live te volgen door toediening in MRI-scanner
feb 2022 | Maag-darm-leveroncologie, Radiotherapie